GraphiqueCollé-3.png
Innoskel Announces First Patient Enrolled in Observational Study to Evaluate Children Living with Type II Collagen Disorders
13 juil. 2022 02h00 HE | InnoSkel
Innoskel Announces First Patient Enrolled in Observational Study to Evaluate Children Living with Type II Collagen Disorders Study will build a type II collagen disorder observational data set to...
GraphiqueCollé-3.png
Innoskel Appoints Dr Michel Detheux as Chairman
12 avr. 2022 02h00 HE | InnoSkel
Innoskel Appoints Dr Michel Detheux as Chairman Nice, France, 12 April 2022 – Innoskel (the “Company”), a pioneering biotechnology company developing transformative therapies for the unmet needs of...
GraphiqueCollé-3.png
InnoSkel awarded Innovation Passport by the UK MHRA for the treatment of a rare bone disorder
16 déc. 2021 02h00 HE | InnoSkel
InnoSkel awarded Innovation Passport by the UK MHRA for the treatment of a rare bone disorder First step in the recent UK MHRA initiative to accelerate the development and access to innovative...
GraphiqueCollé-3.png
InnoSkel Appoints Dr Sophie Amsellem-Bosq as Chief Technical Officer
14 déc. 2021 02h00 HE | InnoSkel
InnoSkel Appoints Dr Sophie Amsellem-Bosq as Chief Technical Officer Nice, France, 14 December 2021 – InnoSkel (the “Company”), a pioneering platform biotechnology company developing transformative...
GraphiqueCollé-3.png
Innoskel Founder and CEO, Elvire Gouze, PhD Receives EY Entrepreneur Of The Year™ Southeast France 2021 Award
30 sept. 2021 06h00 HE | InnoSkel
Innoskel Founder and CEO, Elvire Gouze, PhD Receives EY Entrepreneur Of The Year™ Southeast France 2021 Award Award recognizes Dr. Gouze’s leadership to transform the treatment paradigm for...
GraphiqueCollé-3.png
INNOSKEL EXPANDS LEADERSHIP TEAM TO ACCELERATE DEVELOPMENT OF LEAD PROGRAM AND DRIVE PLATFORM INNOVATION
25 mai 2021 02h00 HE | InnoSkel
INNOSKEL EXPANDS LEADERSHIP TEAM TO ACCELERATE DEVELOPMENT OF LEAD PROGRAM AND DRIVE PLATFORM INNOVATIONDavid Favre PhD Appointed Chief Scientific Officer and Samantha Parker Appointed Chief Patient...
GraphiqueCollé-3.png
InnoSkel Launches with €20 Million Series A Financing
14 déc. 2020 01h00 HE | InnoSkel
InnoSkel Launches with €20 Million Series A Financing Proceeds to support development and advancement of innovative gene therapies for patients with rare skeletal diseases Founded and led by...